Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ansata Therapeutics Inc.

www.ansatainc.com

Latest From Ansata Therapeutics Inc.

Drug Delivery: Moving from Platform to Product

The traditional drug-delivery business model of service for hire has fallen from popularity. Big Pharmas are doing few deals of this sort, and investors want bigger returns than fees and royalties can provide. Start-ups with drug delivery technologies are increasingly using their platforms on their own behalf, to create products they can out-license or possibly market themselves. Now content--getting the molecules to be delivered--is an issue.
BioPharmaceutical Strategy

Selected Start-Ups (1/03)

In Vivo briefly summarizes the technologies of these recently founded companies: Ansata Inc., BioRexis Pharmaceutical Corp., Dentigenix LLC, DermaCo Inc., PhysioGenix Inc. and Zivena Inc.
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ansata Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Ansata Therapeutics Inc.
  • Senior Management
  • Dee Conger, CEO
    Brian Pollok, PhD, SVP, Research
  • Contact Info
  • Ansata Therapeutics Inc.
    Phone: (858) 754-3000
    505 Coast Blvd. S.
    La Jolla, CA 92037
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register